Etsy exploded 88% out of the gate, giving it the best first-day return for a tech IPO in over a year. Cancer immunotherapy biotech Aduro Biotech flew up 147%, the year's third IPO to more than double on day one.
This past week was the second largest of 2015...read more
Cidara Therapeutics, a preclinical biotech developing novel therapies for fungal infections, raised $77 million by offering 4.8 million shares at $16, the high end of the range of $14 to $16. Cidara Therapeutics plans to list on the NASDAQ under the symbol...read more
As many as seven IPOs could price this week, and four have a proposed market cap over $1 billion. So far, only eight companies that large have gone public this year, or 22% of all...read more
Cidara Therapeutics, which is developing novel therapies for fungal infections, announced terms for its IPO on Monday. The San Diego, CA-based company plans to raise $60 million by offering 4.0 million shares at a price range of $14 to $16. At the midpoint...read more
US IPO Weekly Recap: 7 IPOs see Etsy vault 70%, proving vintage is in vogue
Etsy exploded 88% out of the gate, giving it the best first-day return for a tech IPO in over a year. Cancer immunotherapy biotech Aduro Biotech flew up 147%, the year's third IPO to more than double on day one. This past week was the second largest of 2015...read more
Cidara Therapeutics prices IPO at $16, the high end of the range
Cidara Therapeutics, a preclinical biotech developing novel therapies for fungal infections, raised $77 million by offering 4.8 million shares at $16, the high end of the range of $14 to $16. Cidara Therapeutics plans to list on the NASDAQ under the symbol...read more
Week ahead: Crafts, cancer cures and cash flow in a week with 7 IPOs including Party City
As many as seven IPOs could price this week, and four have a proposed market cap over $1 billion. So far, only eight companies that large have gone public this year, or 22% of all...read more
Fungus fighter Cidara Therapeutics sets terms for $60 million IPO
Cidara Therapeutics, which is developing novel therapies for fungal infections, announced terms for its IPO on Monday. The San Diego, CA-based company plans to raise $60 million by offering 4.0 million shares at a price range of $14 to $16. At the midpoint...read more